Cargando…
Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases
BACKGROUND: This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus disease 2019 (COVID-19) in pediatric patients with rheumatic and musculoskeletal diseases (RMD) and identify the risk factors associated with symptomatic or severe disease defined as hospital adm...
Autores principales: | Clemente, Daniel, Udaondo, Clara, de Inocencio, Jaime, Nieto, Juan Carlos, del Río, Pilar Galán, Fernández, Antía García, Palomo, Jaime Arroyo, Bachiller-Corral, Javier, Lopez Robledillo, Juan Carlos, Millán Longo, Claudia, Leon, Leticia, Abasolo, Lydia, Boteanu, Alina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626725/ https://www.ncbi.nlm.nih.gov/pubmed/34838054 http://dx.doi.org/10.1186/s12969-021-00648-5 |
Ejemplares similares
-
High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study
por: Loarce-Martos, Jesús, et al.
Publicado: (2020) -
Consensus statement on the transition process from pediatric care to adult care in patients with chronic inflammatory rheumatic diseases with childhood-onset
por: Calvo, Inmaculada, et al.
Publicado: (2014) -
Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases
por: Leon, Leticia, et al.
Publicado: (2022) -
Hospital admissions in inflammatory rheumatic diseases during the peak of COVID-19 pandemic: incidence and role of disease-modifying agents
por: Fernandez-Gutierrez, Benjamin, et al.
Publicado: (2021) -
Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases—cross-sectional study from a reference centre in Spain
por: Udaondo, Clara, et al.
Publicado: (2022)